Bio-Connect

SARS-CoV-2 (COVID-19) Nucleocapsid antibody

GTX135361
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV-2 (COVID-19) Nucleocapsid antibody
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody detects SARS-CoV-2 nucleocapsid protein, but does not cross-react with SARS-CoV or MERS-CoV nucleocapsid proteins based on our internal testing.
  • Application Supplier Note
    WB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Reactivity
    Virus
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants.
    Read more
  • Type I interferon-dependent IFIT3 signaling is critical for viral clearance in airway neutrophils.
    Read more
  • Spatial transcriptomic profiling of coronary endothelial cells in SARS-CoV-2 myocarditis.
    Read more
  • Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2.
    Read more
  • SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming.
    Read more
  • SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
    Read more
  • Asymmetric Mach-Zehnder Interferometric Biosensing for Quantitative and Sensitive Multiplex Detection of Anti-SARS-CoV-2 Antibodies in Human Plasma.
    Read more
  • Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients. Pipolo C et al., 2022, PLoS One
    Read more
  • Gastrointestinal Manifestations of COVID-19 Infection: Clinicopathologic Findings in Intestinal Resections Performed at Single Institution. Burkett AE et al., 2022, Front Med (Lausanne)
    Read more
  • BCG vaccination provides protection against IAV but not SARS-CoV-2. Kaufmann E et al., 2022 Mar 8, Cell Rep
    Read more